KIT and acute myeloid leukemia: Significantly higher production of intracellular INFy in MLCWB-DC(Kit M) compared to MLCWB-DC(Control) was found in, e.g., CD3+INFy+, TCD4−INFy+, (%CD3+INFy+/CD3+: Kit M: 32 ± 15; Control: 14 ± 10; p = 0.006 and %TCD4+INFy+/TCD4+: Kit M: 50 ± 26; Control: 24 ± 17; p = 0.016 (Figure 3B ‘AML’).